Shelia Williams
Nurse Practitioner · Mineola, TXNPI 1346550126
Payments from drug & device makers
Across 336 payments — averaging $17.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$1K
- AstraZeneca$767
- Boehringer Ingelheim$598
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$441
- Novo Nordisk$371
- Lilly USA, LLC$357
- plus $2K from 28 others
What the payments were for
- Food & beverage$5,846100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 75 | $1,034 |
| AstraZeneca | 35 | $767 |
| Boehringer Ingelheim | 36 | $598 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 23 | $441 |
| Novo Nordisk | 23 | $371 |
| Lilly USA, LLC | 26 | $357 |
| Idorsia Pharmaceuticals US Inc | 9 | $237 |
| AbbVie | 10 | $185 |
| Supernus Pharmaceuticals, Inc. | 13 | $184 |
| Tris Pharma Inc | 9 | $155 |
| Amgen | 9 | $128 |
| Jazz Pharmaceuticals Inc. | 1 | $111 |
| Merck | 7 | $104 |
| Otsuka America Pharmaceutical, Inc. | 5 | $103 |
| Bayer | 6 | $102 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $100 |
| Vanda Pharmaceuticals Inc. | 5 | $100 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 6 | $89 |
| Pfizer | 3 | $88 |
| Teva Pharmaceuticals USA, Inc. | 4 | $73 |
| Exact Sciences | 5 | $72 |
| Amarin Pharma, Inc. | 3 | $70 |
| Corium, LLC | 4 | $59 |
| Sumitomo Pharma America, Inc. | 3 | $58 |
| Nevro Corp. | 3 | $53 |
| Corcept Therapeutics | 1 | $43 |
| Paratek Pharmaceuticals, Inc. | 2 | $37 |
| Kowa Pharmaceuticals America, Inc. | 2 | $24 |
| Sunovion Pharmaceuticals Inc. | 2 | $23 |
| Axsome Therapeutics, Inc. | 1 | $21 |
| Evoke Pharma, Inc. | 1 | $18 |
| Alkermes, Inc. | 1 | $18 |
| Novartis | 1 | $13 |
| Arbor Pharmaceuticals, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,846 in reported general payments places this provider in the 95th percentile of 5,422 nurse practitioner providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 39 | $39,047 |
| EliquisApixaban | 28 | $33,412 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 13 | $14,888 |
| SymbicortBudesonide/Formoterol Fumarate | 12 | $3,904 |
| Rosuvastatin Calcium | 110 | $1,736 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 40 | $1,295 |
| Clonidine | 12 | $1,217 |
| Gabapentin | 54 | $1,159 |
| Omeprazole | 65 | $1,144 |
| Ventolin HfaAlbuterol Sulfate | 18 | $1,010 |
| Levothyroxine Sodium | 112 | $974 |
| Atorvastatin Calcium | 104 | $877 |
| Estradiol | 19 | $841 |
| Losartan Potassium | 88 | $675 |
| Lisinopril-HydrochlorothiazideLisinopril/Hydrochlorothiazide | 65 | $626 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance | $598 | $39,04739 claims |
| PfizerEliquis | $88 | $33,41228 claims |
| GSKTrelegy Ellipta | $1,034 | $14,88813 claims |
| AstraZenecaSymbicort | $767 | $3,90412 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 5,422 nurse practitioner providers in Texas.
Other nurse practitioner in Mineola
- Cecilia DavisAustin$262K
- Melanie MorrisHouston$254K
- Stephanie BrownHarlingen$235K
- Brittney MisercolaKilleen$223K
- Roger ChapmanTyler$211K
- Kelly BrassilHouston$194K
- Corrie BerkSan Antonio$155K
- Samantha OnealDallas$133K
- Monica WhiteLongview$118K
- Onna FeuchterSouthlake$108K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.